Saponin-mediated adjuvant effect

The "saponin-mediated adjuvant effect" refers to the powerful immunostimulatory activities of saponin natural products—plant-derived amphipathic glycosides, such as QS-21—used as adjuvants to enhance vaccine efficacy. Saponin adjuvants potentiate immune responses via multiple mechanisms, including induction of cytokines, recruitment and activation of APCs, facilitation of antigen uptake and cross-presentation, and enhancement of both humoral (antibody) and cellular (T cell) immune responses. Structural features of saponins (e.g., specific carbohydrate branches, acyl chains, and triterpene cores) are closely linked to their adjuvant effect, and some saponins, notably QS-21, are components of licensed vaccines (e.g., Shingrix, RTS,S/AS01). Saponin-mediated adjuvant activity is not restricted to a single molecular target, but involves interactions with various immune pathways, including potential receptor-mediated effects and activation of intracellular complexes (e.g., NLRP3) [1][2][3][4].

Other names

Saponin adjuvant effectQS-21 adjuvanticitysaponin-based adjuvant mechanism

Activation of antigen-presenting cells (APCs), including dendritic cells and macrophages [1][2][4] Recruitment of immune cells via cytokine induction [1] Promotion of antigen uptake and cross-presentation [1][4] Activation of intracellular pattern recognition receptors (e.g., NLRP3 inflammasome) [4] Modulation of antibody isotype responses (shifting Th1/Th2 balance) [2]